A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)
T. Kinoshita(Chiba Rosai Hospital), Jun‐ichi Kadota(Oita University)
Cited by 37
Related Papers
No related papers found
Powered by citation graph analysis